找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Cases in Psoriasis; Jashin J. Wu Book 20171st edition Springer International Publishing AG 2017 psoriasis.biologics.phototherapy.

[復制鏈接]
樓主: 落后的煤渣
51#
發(fā)表于 2025-3-30 10:08:49 | 只看該作者
Severely Obese 42-Year-Old with Psoriasis,o weigh more, first-line biological drug choices include infliximab and ustekinumab because they are weight based. On the other hand, systemic treatments can often cause adverse effects and metabolic derangements in these patients.
52#
發(fā)表于 2025-3-30 16:19:00 | 只看該作者
33-Year-Old Female with Psoriasis Planning for Pregnancy,sis if she were to become pregnant. She and her spouse were planning on conceiving a child in 6 months. Her current treatment regimen included adalimumab and methotrexate. She denied experiencing side effects with her medications. She was otherwise healthy and does not have any other medical illnesses.
53#
發(fā)表于 2025-3-30 20:28:16 | 只看該作者
https://doi.org/10.1007/978-3-319-52779-6psoriasis; biologics; phototherapy; cyclosporine; methotrexate; acitretin; apremilast; hepatitis; herpes zos
54#
發(fā)表于 2025-3-31 00:06:12 | 只看該作者
Springer International Publishing AG 2017
55#
發(fā)表于 2025-3-31 02:38:27 | 只看該作者
56#
發(fā)表于 2025-3-31 08:53:39 | 只看該作者
Why States Desire for Missile Systems?,eeking an alternative treatment after multiple years of topical corticosteroid use with suboptimal results and difficulty applying the ointment on his entire body. The patient has a family history of psoriasis. He did not complain of joint tenderness, swelling, or stiffness.
57#
發(fā)表于 2025-3-31 12:58:44 | 只看該作者
58#
發(fā)表于 2025-3-31 17:11:31 | 只看該作者
Role Transition as Social Dramae patient was referred to dermatology after failed empiric treatment with topical antifungal creams prescribed by his primary care physician. He reports being otherwise healthy and denied a family history of psoriasis.
59#
發(fā)表于 2025-3-31 19:23:47 | 只看該作者
https://doi.org/10.1007/b138916o weigh more, first-line biological drug choices include infliximab and ustekinumab because they are weight based. On the other hand, systemic treatments can often cause adverse effects and metabolic derangements in these patients.
60#
發(fā)表于 2025-4-1 00:32:39 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 16:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
彝良县| 大竹县| 米易县| 巴林右旗| 谢通门县| 左云县| 余庆县| 策勒县| 屯昌县| 电白县| 珲春市| 玉山县| 海伦市| 若羌县| 吉林市| 东兰县| 娄烦县| 绥滨县| 汝州市| 台北县| 靖宇县| 石城县| 凤凰县| 鹤庆县| 兰坪| 靖江市| 江安县| 元氏县| 双鸭山市| 奎屯市| 贵德县| 同心县| 阿坝县| 罗平县| 纳雍县| 松桃| 新宾| 皮山县| 太康县| 烟台市| 嘉善县|